Prevent Cancer Foundation welcomes largest-ever Corporate Membership Program cohort in 2026
برای انتشار فوری
کایرا مایستر
703-836-1746
kyra.meister@preventcancer.org
الکساندریا، ویرجینیا - بنیاد پیشگیری از سرطان® is proud to welcome 23 leading companies to its Corporate Membership Program. Together, they make up the program’s largest-ever cohort, strengthening a growing network of business leaders dedicated to reducing the impact of cancer through prevention and early detection.
Program members receive exclusive access to Foundation events and resources while providing vital support for the Foundation’s work in education, outreach, advocacy and community. Through collaboration and the exchange of ideas, members help advance cancer prevention and early detection efforts, empowering people to take steps that can improve health outcomes and save more lives.
“Our corporate partners play a vital role in advancing cancer prevention and early detection nationwide,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “We’re proud to work alongside companies that share our vision of a world where cancer is preventable, detectable and beatable for all.”
The 2026 class of corporate members, as of the date of this publication, include:
Silver members
- Abbott
- بریستول مایرز اسکوئیب
- هولوژیک
- فایزر
- PhRMA
Bronze members
- AbbVie
- Astellas
- AstraZeneca
- Boehringer Ingelheim
- عیسی
- Eli Lilly & Co
- Exelixis
- Freenome
- Genentech
- Geneoscopy
- GSK
- ضامن سلامت
- مرک
- Mercy BioAnalytics
- Natera
- Novartis
- سانوفی
The Corporate Membership Program is open to companies who support the Foundation’s mission: Stopping Cancer. Saving Lives. To learn more or inquire about joining, contact Anne Potter, Senior Director of Corporate and Foundation Relations, at anne.potter@prevencancer.org.
###
درباره بنیاد پیشگیری از سرطان®
بنیاد پیشگیری از سرطان® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, advocacy and community, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.
این بنیاد در حال افزایش است تا با چالش کاهش مرگ و میر ناشی از سرطان تا 40% تا سال 2035 مقابله کند. برای دستیابی به این هدف، ما متعهد به سرمایه گذاری $20 میلیون برای فناوری های نوآورانه برای تشخیص زودهنگام سرطان و پیشبرد غربالگری چند سرطانی، $10 میلیون برای گسترش غربالگری سرطان و واکسیناسیون هستیم. دسترسی به جوامع محروم از نظر پزشکی و $10 میلیون برای آموزش مردم در مورد گزینه های غربالگری و واکسیناسیون.
برای اطلاعات بیشتر لطفا مراجعه کنید به www.preventcancer.org.